Author

Fengxian Jiang

Observed name: Jiang, Fengxian

Institutions: Shandong Provincial Hospital, Second Affiliated Hospital of Soochow University, Shandong First Medical University

Observed institutions: Shandong University of Traditional Chinese Medicine, Shandong Provincial Hospital, Second Affiliated Hospital of Soochow University, Shandong First Medical University

ORCID: 0000-0003-3160-2453

Observed ORCID: 0000-0003-3160-2453

OpenAlex ID: A5037721911

Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology

2022 · Jingjiang Lai, Fengxian Jiang, et al. · Chinese Medicine · 30

PDF

The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis

2024 · Rui Zhao, Yang Shu, et al. · Cancer Cell International · 26

PDF

Engineered probiotic-derived indole-3-propionic acid inhibits ubiquitination via AHR signaling to treat postmenopausal osteoporosis

2026 · Xueli Qiu, Lijun Wu, et al. · Gut Microbes · 15

Polysaccharide from Atractylodes macrocephala Koidz. alleviates pyrotinib-induced diarrhea through regulating cAMP/LKB1/AMPK/CFTR pathway and restoring gut microbiota and metabolites

2025 · Pancen Ran, Fengxian Jiang, et al. · International Journal of Biological Macromolecules · 12

Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomics

2022 · Jingjiang Lai, Xiaoli Zhuo, et al. · Anti-Cancer Drugs · 8

Mechanism of Atractylenolide Ⅲ alleviating pyrotinib-induced diarrhea by regulating AMPK/CFTR pathway through metabolite of gut microbiota

2024 · Fengxian Jiang, Pancen Ran, et al. · Journal of Traditional and Complementary Medicine · 7

Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy

2024 · Fang Luan, Jingliang Wang, et al. · International Immunopharmacology · 7

Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation

2023 · Jing Zhao, Wei Xu, et al. · The Oncologist · 6

PDF

HER2-positive breast cancer progresses rapidly after pyrotinib resistance: acquired RET gene fusion and TP53 gene mutation are potential reasons

2023 · Fengxian Jiang, Jingjiang Lai, et al. · Anti-Cancer Drugs · 6

Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations

2022 · Xiaoli Zhuo, Honglin Guo, et al. · Journal of Cancer Research and Clinical Oncology · 6

Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers

2025 · Jingliang Wang, Weihao Wang, et al. · PLoS ONE · 5

PDF

Role of Bile Acid Receptors in Non-Infectious Diarrhea: A Narrative Review

2026 · Liying Pan, Pancen Ran, et al. · Medical Science Monitor

PDF

Clinical and CT image features for survival prediction in severe pneumonia during the SARS-CoV-2 Omicron wave

2026 · Wei Xu, Jing Zhao, et al. · Frontiers in Medicine

PDF

Shenling Baizhu powder alleviates pyrotinib-induced diarrhea via CFTR-activated chloride secretion

2025 · Jingjiang Lai, Liying Pan, et al. · Journal of Ethnopharmacology

Implications of Bile Acids Activated Receptors in non-infectious diarrhea

2025 · Liying Pan, Pancen Ran, et al.

Corrigendum to “Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy” [Int. Immunopharmacol. 131 (2024) 111823]

2024 · Fang Luan, Jingliang Wang, et al. · International Immunopharmacology

Mechanisms of Atractylodes macrocephala Koidz. on therapy to diarrheal disease: A systematical review and meta-analysis of preclinical evidence

2024 · Pancen Ran, Fengxian Jiang, et al. · Research Square

PDF

Works count: 19

Citation count: 128

H-index: 7

I10-index: 4